Edition:
United States

Elekta AB (publ) (EKTAb.ST)

EKTAb.ST on Stockholm Stock Exchange

125.15SEK
20 Aug 2018
Change (% chg)

0.90kr (+0.72%)
Prev Close
124.25kr
Open
124.25kr
Day's High
125.35kr
Day's Low
124.15kr
Volume
92,107
Avg. Vol
1,312,228
52-wk High
128.70kr
52-wk Low
66.12kr

Latest Key Developments (Source: Significant Developments)

Pennsylvania Hospitals Buys Advanced Cancer Management Systems From Elekta
Friday, 18 May 2018 01:38am EDT 

May 18 (Reuters) - Elekta AB (publ) ::PENNSYLVANIA HOSPITALS ACQUIRE ADVANCED CANCER MANAGEMENT SYSTEMS FROM ELEKTA.ACQUISITION IS PART OF AN EXCLUSIVE AGREEMENT SIGNED IN 2014.  Full Article

Elekta has won order in ‍Egypt, was booked in Q3 ​
Friday, 6 Apr 2018 01:30am EDT 

April 6 (Reuters) - Elekta AB (publ) ::SAYS EGYPT HAS AGAIN CHOSEN ELEKTA tO EQUIP ITS MINISTRY OF HEALTH HOSPITALS, INCLUDING NATIONAL CANCER INSTITUTE (NCI) IN CAIRO​.SAYS ‍HOSPITALS WILL ACQUIRE AN ELEKTA VERSA HD, THREE ELEKTA SYNERGY PLATFORM LINEAR ACCELERATORS AS WELL AS ELEKTA'S MOSAIQ ONCOLOGY INFORMATION SYSTEM AND MONACO TREATMENT PLANNING SYSTEM AND SERVICES​.ELEKTA AB SAYS ‍ORDER WAS BOOKED IN Q3 OF ELEKTA'S 2017/18 FISCAL YEAR AND FIRST DELIVERIES OF LINEAR ACCELERATORS ARE EXPECTED IN AUGUST, 2018.​.  Full Article

Elekta AB Q3 profit and orders top forecasts, cuts full-year margin target
Friday, 2 Mar 2018 01:30am EST 

March 2 (Reuters) - Elekta AB ::Q3 ‍GROSS ORDER INTAKE AMOUNTED TO SEK 3,833 M (3,653), AN INCREASE OF 9 PERCENT BASED ON CONSTANT EXCHANGE RATES AND 5 PERCENT IN SEK​.Q3 ‍ADJUSTED EBITA* AMOUNTED TO SEK 502 M (325)​.Q3 ‍ADJUSTED EBITA MARGIN* WAS 18 PERCENT (12)​.Q3 ‍TWO NEW ELEKTA UNITY ORDERS WERE BOOKED IN QUARTER​.SAYS ‍WE REMAIN COMMITTED TO REACHING AN EBITA MARGIN OF OVER 20 PERCENT​.SAYS ‍THIS FISCAL YEAR WE EXPECT TO REACH AN EBITA MARGIN OF AROUND 19 PERCENT.THE COMPANY HAS BEEN TARGETING AN EBITA MARGIN OF MORE THAN 20 PERCENT IN FISCAL YEAR 2017/18​.REUTERS POLL: ELEKTA FISCAL Q3 ORDER INTAKE SEEN AT SEK 3,288 MILLION, ADJUSTED EBITA AT SEK 483 MILLION.  Full Article

C-Rad Updates On Delivery To Swedish Cancer Center
Wednesday, 13 Dec 2017 02:30am EST 

Dec 13 (Reuters) - C-Rad Ab ::REG-UPDATE ON C-RAD DELIVERY OF ITS ADVANCED SURFACE TRACKING SOLUTION TO SWEDISH CANCER CENTER NYA KAROLINSKA SOLNA.SAYS ‍IS IN CLOSE DIALOGUE WITH CUSTOMER AND WITH ELEKTA TO DETERMINE STEPS FORWARD.​.  Full Article

Elekta reaches agreement in dispute with Stockholm County Council
Tuesday, 12 Dec 2017 07:00am EST 

Dec 12 (Reuters) - Elekta AB ::ELEKTA AND STOCKHOLM COUNTY COUNCIL AGREE ON CONSTRUCTIVE WAY FORWARD.SAYS ELEKTA AND STOCKHOLM COUNTY COUNCIL SIGNED A LETTER OF INTENT TODAY REGARDING THE AGREEMENT FROM DECEMBER 29, 2016.SAYS ‍ELEKTA WILL CONTINUE TO FULLY EQUIP NEW RADIATION THERAPY DEPARTMENT OF STOCKHOLM SOUTH GENERAL HOSPITAL (SÖS) AND TO PROVIDE BRACHYTHERAPY SOLUTIONS TO NEW KAROLINSKA SOLNA (NKS).SAYS STOCKHOLM COUNTY COUNCIL WILL HAVE THE POSSIBILITY TO SEEK A SEPARATE SOLUTION FOR THE REMAINING EXTERNAL BEAM EQUIPMENT AT NKS​.SAYS VALUE OF REMAINING PART OF CONTRACT IS EXPECTED TO BE APPROXIMATELY SEK 160 MILLION; INITIAL ORDER VALUE WAS APPROXIMATELY SEK 350 MILLION.SAYS ‍LETTER OF INTENT IS EXPECTED TO BE TURNED INTO A BINDING CONTRACT LATEST JANUARY 31, 2018​.  Full Article

Elekta CEO: Unity radiation therapy system a 2018 sales driver
Thursday, 30 Nov 2017 05:00am EST 

Nov 30 (Reuters) - Elekta AB CEO Richard Hausmann and CFo Gustaf Salford in a conference call with analysts and media::CEO SAYS OVERALL, THE UNITY RADIATION THERAPY PROJECT IS PROGRESSING VERY WELL.CFO SAY SEES FULL-YEAR POSITIVE CURRENCY EFFECT ON EBITA AT AROUND 150 MILLION SEK Y/Y.CEO SAYS EXPECTS UNITY RADIATION THERAPY SYSTEM TO BE A SALES GROWTH DRIVER IN 2018.  Full Article

Elekta Q2 core profit beat expectations, orders lag
Thursday, 30 Nov 2017 01:30am EST 

Nov 30 (Reuters) - Elekta Ab ::Q2 ‍GROSS ORDER INTAKE AMOUNTED TO SEK 3,267 M (3,383),​.SAYS ‍OUR TARGETS FOR YEAR ARE CLEAR - WE WILL DELIVER PROFITABLE GROWTH AND REACH AN EBITA MARGIN EXCEEDING 20 PERCENT THROUGH GROWTH AND OUR WORK WITH CONTINUOUS OPERATIONAL IMPROVEMENTS​.Q2 ‍NET SALES WAS SEK 2,802 M (2,434)​.Q2 ‍ADJUSTED EBITA* AMOUNTED TO SEK 509 M (391)​.REUTERS POLL: ELEKTA FISCAL Q2 ORDER INTAKE SEEN AT SEK 3.5 BILLION, ADJUSTED EBITA AT SEK 432 MILLION.REUTERS POLL: ELEKTA FISCAL Q2 ORDER INTAKE SEEN AT SEK 3.5 BILLION, ADJUSTED EBITA AT SEK 432 MILLION.SAYS ON ELEKTA UNITY: WE ADJUST OUR TARGET FOR THE FIRST 75 ORDERS TO THE FIRST HALF OF CALENDAR YEAR 2020‍​.  Full Article

Elekta says CE mark for Unity is expected during first half of 2018
Friday, 10 Nov 2017 01:30am EST 

Nov 10 (Reuters) - Elekta Ab (Publ) :Elekta has decided to add additional functional imaging capabilities to its MR-linac (Unity) and to spend more time on validating its linac control system .CE mark for Unity is currently expected during the first half of 2018 instead of the end of 2017..  Full Article

Elekta Q1 core profit lags expectations, orders in line
Wednesday, 23 Aug 2017 01:30am EDT 

Aug 23 (Reuters) - Elekta Ab (Publ) :q1 net sales was sek 2,169 m.q1 adjusted ebita* amounted to sek 187 m.q1 gross order intake amounted to sek 2,738 m.Reuters poll average forecasts were for adjusted EBITA of 244 mln SEK, sales 2,148 mln, orders 2,736 mln .Says We will return to profitable growth and with continuous process improvements and cost savings we reiterate our target of an ebita margin exceeding 20 percent.Says on Elekta Unity system: We are advancing towards CE-mark and 510k filing that are planned before end of this calendar year and we reiterate our ambition to generate 75 orders until year end 2019 .  Full Article

Isala and Elekta sign 15- year partnership agreement for optimal cancer care
Tuesday, 27 Jun 2017 12:10pm EDT 

June 27 (Reuters) - Elekta Ab (Publ) :Co, Isala signed a 15-year partnership agreement to implement latest developments in oncology and radiotherapy at Isala.Elekta and Isala also announced start of a long-term technology partnership for radiotherapy and oncology.  Full Article

UPDATE 1-Elekta Q4 adjusted operating profit below forecasts, dividend higher

June 1 Swedish radiation therapy equipment maker Elekta on Friday reported below-forecast earnings for its fiscal fourth quarter, but proposed a higher dividend than expected.